80_FR_28342 80 FR 28247 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

80 FR 28247 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

DEPARTMENT OF DEFENSE
Office of the Secretary

Federal Register Volume 80, Issue 95 (May 18, 2015)

Page Range28247-28248
FR Document2015-11977

The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel).

Federal Register, Volume 80 Issue 95 (Monday, May 18, 2015) 
[Federal Register Volume 80, Number 95 (Monday, May 18, 2015)]
[Notices]
[Pages 28247-28248]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-11977]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Assistant Secretary of Defense (Health Affairs), DoD.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense is publishing this notice to 
announce a Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (hereafter referred to as the Panel).

DATES: Thursday, June 11, 2015, from 9:00 a.m. to 1:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Mr. William H. Blanche, Alternate DFO, 
Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, 
Suite 5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890. 
Fax: (703) 681-1940. Email Address: dha.ncr.health-it.mbx.baprequests@mail.mil.

SUPPLEMENTARY INFORMATION: 
    This meeting is being held under the provisions of the Federal 
Advisory Committee Act of 1972 (Title 5, United States Code (U.S.C.), 
Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 
U.S.C. 552b, as amended).
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director of Defense Health Agency, by the 
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.

Meeting Agenda

1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Newer Oral Anticoagulants and Warfarin
    b. Hepatitis Antivirals (Hepatitis C)
5. Designated Newly Approved Drugs in Already-Reviewed Classes
6. Pertinent Utilization Management Issues
    7. Panel Discussions and Vote

    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and 
the availability of space, this meeting is open to the public. Seating 
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
    Administrative Work Meeting: Prior to the public meeting, the Panel 
will conduct an Administrative Work Meeting from 8:00 a.m. to 9:00 a.m. 
to discuss administrative matters of the Panel. The Administrative Work 
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania 
Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the 
Administrative Work Meeting will be closed to the public.
    Written Statements: Pursuant to 41 CFR 102-3.140, the public or 
interested organizations may submit written statements to the 
membership of the Panel at any time or in response to the stated agenda 
of a planned meeting. Written statements should be submitted to the 
Panel's Designated Federal Officer

[[Page 28248]]

(DFO). The DFO's contact information can be obtained from the General 
Services Administration's Federal Advisory Committee Act Database at 
http://facadatabase.gov/.
    Written statements that do not pertain to the scheduled meeting of 
the Panel may be submitted at any time. However, if individual comments 
pertain to a specific topic being discussed at a planned meeting, then 
these statements must be submitted no later than 5 business days prior 
to the meeting in question. The DFO will review all submitted written 
statements and provide copies to all the committee members.
    Public Comments: In addition to written statements, the Panel will 
set aside 1 hour for individuals or interested groups to address the 
Panel. To ensure consideration of their comments, individuals and 
interested groups should submit written statements as outlined in this 
notice; but if they still want to address the Panel, then they will be 
afforded the opportunity to register to address the Panel. The Panel's 
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for 
registration on a first-come, first-serve basis. Those wishing to 
address the Panel will be given no more than 5 minutes to present their 
comments, and at the end of the 1 hour time period, no further public 
comments will be accepted. Anyone who signs-up to address the Panel, 
but is unable to do so due to the time limitation, may submit their 
comments in writing; however, they must understand that their written 
comments may not be reviewed prior to the Panel's deliberation.
    To ensure timeliness of comments for the official record, the Panel 
encourages that individuals and interested groups consider submitting 
written statements instead of addressing the Panel.

    Dated: May 13, 2015.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2015-11977 Filed 5-15-15; 8:45 am]
 BILLING CODE 5001-06-P

Federal Register / Vol. 80, No. 95 / Monday, May 18, 2015 / Notices 28247 of the information to be collected; and transfers (TDY and PCS), for FOR FURTHER INFORMATION CONTACT: Mr. (d) ways to minimize the burden of the modification of privileges, and for William H. Blanche, Alternate DFO, information collection on respondents, renewal of privileges and staff Uniform Formulary Beneficiary including through the use of automated reappointment within the system. Advisory Panel, 7700 Arlington collection techniques or other forms of CCQAS was CAC enforced December Boulevard, Suite 5101, Falls Church, VA information technology. 2009 and as part of the Federal Health 22042–5101. Telephone: (703) 681– DATES: Consideration will be given to all Care Center, North Chicago, VA PIV 2890. Fax: (703) 681–1940. Email comments received by July 17, 2015. users gained access in October 2010. In Address: dha.ncr.health- ADDRESSES: You may submit comments, November 2011, CCQAS was PKI/SSO it.mbx.baprequests@mail.mil. identified by docket number and title, integrated. SUPPLEMENTARY INFORMATION: by any of the following methods: Affected Public: Individuals or This meeting is being held under the • Federal eRulemaking Portal: http:// Households. provisions of the Federal Advisory www.regulations.gov. Follow the Annual Burden Hours: 80,000. Committee Act of 1972 (Title 5, United instructions for submitting comments. Number of Respondents: 40,000. States Code (U.S.C.), Appendix, as • Mail: Department of Defense, Office Responses per Respondent: 1. amended) and the Government in the of the Deputy Chief Management Average Burden per Response: 2 Sunshine Act of 1976 (5 U.S.C. 552b, as Officer, Directorate of Oversight and hours. amended). Compliance, Regulatory and Audit Frequency: On occasion. Purpose of Meeting: The Panel will Matters Office, 9010 Defense Pentagon, Currently, CCQAS provides review and comment on Washington, DC 20301–9010. credentialing, privileging, risk- recommendations made to the Director Instructions: All submissions received management and adverse actions of Defense Health Agency, by the must include the agency name, docket capabilities which support medical Pharmacy and Therapeutics Committee, number and title for this Federal quality assurance activities in the direct regarding the Uniform Formulary. Register document. The general policy care system. CCQAS is fully deployed for comments and other submissions Meeting Agenda world-wide and is used by all Services from members of the public is to make (Army, Navy, Air Force) and 1. Sign-In these submissions available for public Components (Guard, Reserve). CCQAS 2. Welcome and Opening Remarks viewing on the Internet at http:// serves users functioning at the facility 3. Public Citizen Comments www.regulations.gov as they are (defined by an individual UIC), Service, 4. Scheduled Therapeutic Class Reviews received without change, including any and DoD levels. Access to CCQAS (Comments will follow each agenda personal identifiers or contact modules and capabilities within each item) information. module is permissions-based, so that a. Newer Oral Anticoagulants and Any associated form(s) for this users have access tailored to the Warfarin collection may be located within this functions they perform and sensitive b. Hepatitis Antivirals (Hepatitis C) same electronic docket and downloaded information receives maximal 5. Designated Newly Approved Drugs in for review/testing. Follow the protection. Within each module, access Already-Reviewed Classes instructions at http:// control is available to the screen level. 6. Pertinent Utilization Management www.regulations.gov for submitting Dated: May 13, 2015. Issues comments. Please submit comments on 7. Panel Discussions and Vote Aaron Siegel, any given form identified by docket Meeting Accessibility: Pursuant to 5 number, form number, and title. Alternate OSD Federal Register, Liaison Officer, Department of Defense. U.S.C. 552b, as amended, and 41 Code FOR FURTHER INFORMATION CONTACT: To of Federal Regulations (CFR) 102–3.140 [FR Doc. 2015–11971 Filed 5–15–15; 8:45 am] request more information on this through 102–3.165, and the availability BILLING CODE 5001–06–P proposed information collection or to of space, this meeting is open to the obtain a copy of the proposal and public. Seating is limited and will be associated collection instruments, DEPARTMENT OF DEFENSE provided only to the first 220 people please write to the Defense Health signing-in. All persons must sign-in Services Systems (DHSS) Program Office of the Secretary legibly. Executive Office (PEO), ATTN: CDR Administrative Work Meeting: Prior to Patrick Amersbach, Defense Health Uniform Formulary Beneficiary the public meeting, the Panel will Headquarters (DHHQ) 7700 Arlington Advisory Panel; Notice of Federal conduct an Administrative Work Boulevard, Falls Church ,VA 22042– Advisory Committee Meeting Meeting from 8:00 a.m. to 9:00 a.m. to 2902, or call 703–681–0845. discuss administrative matters of the AGENCY: Assistant Secretary of Defense Panel. The Administrative Work SUPPLEMENTARY INFORMATION: (Health Affairs), DoD. Meeting will be held at the Naval Title; Associated Form; and OMB Number: Centralized Credentials ACTION: Notice of meeting. Heritage Center, 701 Pennsylvania Quality Assurance System (CCQAS); Avenue NW., Washington, DC 20004. SUMMARY: The Department of Defense is Pursuant to 41 CFR 102–3.160, the OMB Control Number 0720–TBD. Needs and Uses: CCQAS v2.9.11 is an publishing this notice to announce a Administrative Work Meeting will be automated Tri-Service, Web-based Federal Advisory Committee meeting of closed to the public. asabaliauskas on DSK5VPTVN1PROD with NOTICES database containing credentialing, the Uniform Formulary Beneficiary Written Statements: Pursuant to 41 privileging, risk management, and Advisory Panel (hereafter referred to as CFR 102–3.140, the public or interested adverse actions information on direct the Panel). organizations may submit written healthcare providers in the MHS. DATES: Thursday, June 11, 2015, from statements to the membership of the CCQAS also allows providers to apply 9:00 a.m. to 1:00 p.m. Panel at any time or in response to the for privileges online. This latter ADDRESSES: Naval Heritage Center stated agenda of a planned meeting. capability allows for a privileging Theater, 701 Pennsylvania Avenue NW., Written statements should be submitted workflow for new providers, for Washington, DC 20004. to the Panel’s Designated Federal Officer VerDate Sep<11>2014 18:52 May 15, 2015 Jkt 235001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1

28248 Federal Register / Vol. 80, No. 95 / Monday, May 18, 2015 / Notices (DFO). The DFO’s contact information SUMMARY: In compliance with the (AFMES), 115 Purple Heart Drive, Dover can be obtained from the General Paperwork Reduction Act of 1995, the AFB, DE, 19902–5051, ATTN: Mr. John Services Administration’s Federal Office of the Armed Forces Repository Martin, Legal Counsel, AFMES at (302) Advisory Committee Act Database at Specimen Samples for the Identification 346–8634. http://facadatabase.gov/. or Remains (AFRSSIR), a part of the SUPPLEMENTARY INFORMATION: Written statements that do not pertain Armed Forces Medical Examiner Title; Associated Form; and OMB to the scheduled meeting of the Panel System (AFMES), announces a proposed Number: Donor Specimen Card, OMB may be submitted at any time. However, public information collection and seeks Control Number: 0702–XXXX. if individual comments pertain to a public comment on the provisions Needs and Uses: The information specific topic being discussed at a thereof. Comments are invited on: (a) collected will be used for the planned meeting, then these statements whether the proposed collection of identification of human remains. The must be submitted no later than 5 information is necessary for the proper principal purpose of the information is business days prior to the meeting in performance of the functions of the to identify reference specimen samples question. The DFO will review all agency, including whether the that will routinely be stored and not submitted written statements and information shall have practical utility; analyzed until needed for remains provide copies to all the committee (b) the accuracy of the agency’s estimate identification program purposes. members. of the burden of the proposed Affected Public: Individuals or Public Comments: In addition to information collection; (c) ways to Households and Federal Government. written statements, the Panel will set enhance the quality, utility, and clarity Annual Burden Hours: 62,500. aside 1 hour for individuals or of the information to be collected; and Number of Respondents: 250,000. interested groups to address the Panel. (d) ways to minimize the burden of the Responses per Respondent: 1. To ensure consideration of their information collection on respondents, Average Burden per Response: 15 comments, individuals and interested including through the use of automated minutes. groups should submit written collection techniques or other forms of Frequency: On Occasion. statements as outlined in this notice; but information technology. Respondents are deploying civilian or if they still want to address the Panel, DATES: Consideration will be given to all contractors and military personnel then they will be afforded the comments received by July 17, 2015. family members. The principal purpose opportunity to register to address the of the collection is identify reference ADDRESSES: You may submit comments, Panel. The Panel’s DFO will have a specimen samples that will be stored identified by docket number and title, ‘‘Sign-Up Roster’’ available at the Panel and not analyzed until needed for by any of the following methods: meeting for registration on a first-come, • Federal eRulemaking Portal: http:// remain identification purposes. The first-serve basis. Those wishing to www.regulations.gov. Follow the donors at various military collection address the Panel will be given no more instructions for submitting comments. points and other federal agencies than 5 minutes to present their • Mail: Department of Defense, Office provide a blood sample which is stained comments, and at the end of the 1 hour of the Deputy Chief Management on laboratory grade blood stain card time period, no further public Officer, Directorate of Oversight and (BSC). The identifying information on comments will be accepted. Anyone Compliance, Regulatory and Audit the blood stain card provided the donor who signs-up to address the Panel, but Matters Office, 9010 Defense Pentagon, reflects the individual’s full name, is unable to do so due to the time Washington, DC 20301–9010. signature, social security number (SSN), limitation, may submit their comments Instructions: All submissions received date of birth collection date and branch in writing; however, they must must include the agency name, docket of service. The BSC is air dried and understand that their written comments number and title for this Federal vacuumed sealed in a poly foil pouch. may not be reviewed prior to the Panel’s Register document. The general policy An adhesive label reflecting the donor deliberation. for comments and other submissions information and redacted (SSN) is To ensure timeliness of comments for from members of the public is to make printed on the label, along with the the official record, the Panel encourages these submissions available for public unique accession number. In the event that individuals and interested groups viewing on the Internet at http:// of the donor’s death, the blood sample consider submitting written statements www.regulations.gov as they are is scientifically analyzed and a DNA instead of addressing the Panel. received without change, including any profile is created. This profile is then Dated: May 13, 2015. personal identifiers or contact compared with the post-mortem sample Aaron Siegel, information. Any associated form(s) for obtained at the autopsy for positive Alternate OSD Federal Register Liaison this collection may be located within identification. Officer, Department of Defense. this same electronic docket and Dated: May 12, 2015. [FR Doc. 2015–11977 Filed 5–15–15; 8:45 am] downloaded for review/testing. Follow Aaron Siegel, BILLING CODE 5001–06–P the instructions at http:// Alternate OSD Federal Register Liaison www.regulations.gov for submitting Officer, Department of Defense. comments. Please submit comments on [FR Doc. 2015–11857 Filed 5–15–15; 8:45 am] DEPARTMENT OF DEFENSE any given form identified by docket BILLING CODE 5001–06–P number, form number, and title. Department of the Army FOR FURTHER INFORMATION CONTACT: To asabaliauskas on DSK5VPTVN1PROD with NOTICES [Docket ID: USA–2015–0017] request more information on this proposed information collection or to DEPARTMENT OF EDUCATION Proposed Collection; Comment obtain a copy of the proposal and Request Applications for New Awards; associated collection instruments, Predominantly Black Institutions AGENCY: Armed Forces Medical please write to the Office of the Armed Competitive Grant Program Examiner (AFMES), DoD. Forces Repository of Specimen Samples for the Identification of Remains, Armed AGENCY: Office of Postsecondary ACTION: Notice. Forces Medical Examiner System Education, Department of Education VerDate Sep<11>2014 18:52 May 15, 2015 Jkt 235001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\18MYN1.SGM 18MYN1


Document Created: 2015-12-16 07:39:32
Document Modified: 2015-12-16 07:39:32
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThursday, June 11, 2015, from 9:00 a.m. to 1:00 p.m.
ContactMr. William H. Blanche, Alternate DFO, Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890.
FR Citation80 FR 28247 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR